Corporate News

Director/PDMR Shareholding

09 May 2023

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has received notification that Jag Grewal, Chief Executive Officer, and Chris Lea, Chief Financial Officer, each purchased 69,498 ordinary shares of 4 pence each in the Company ("Ordinary Shares") on 5 May 2023 through the Company's all-employee Share Incentive Plan, at a price of 2.59 pence each. At the same time, these individuals were also awarded (for no consideration) their corresponding Matching Shares under the plan.

A summary of each Directors resultant holdings is below:

Director	Board Position	Number of Partnership Shares acquired under the SIP on 5 May 2023	Number of Matching Shares acquired under the SIP on 5 May 2023	Total beneficial holding of Ordinary Shares following these acquisitions
Director	Board Position			Number of Ordinary Shares	Approximate % of Company's issued share capital
Jag Grewal	CEO	69,498	69,498	2,164,830	0.91%
Chris Lea	CFO	69,498	69,498	2,169,904	0.91%

Contacts:

Omega Diagnostics Group PLC			www.omegadx.com
Jag Grewal, Chief Executive Officer				via Walbrook PR
Chris Lea, Chief Financial Officer

finnCap Ltd			Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)
Alice Lane/Charlotte Sutcliffe (ECM)

Walbrook PR Limited	Tel: 020 7933 8780 or [email protected]
Paul McManus		Mob: 07980 541 893
Lianne Applegarth		Mob: 07584 391 303
Sam Allen		Mob: 07502 558 258

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
www.omegadx.com

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jag Grewal

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Omega Diagnostics Group PLC

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 4 pence each

ISIN: GB00B1VCP282

b)

Nature of the transaction

Ordinary Shares purchased

c)

Price(s) and volume(s)

Price(s)	Volume(s)
2.59 pence	69,498

d)

Aggregated information

-Aggregated volume

- Price

See above

e)

Date of the transaction

05.05.2023

f)

Place of the transaction

London Stock Exchange

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Chris Lea

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Omega Diagnostics Group PLC

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 4 pence each

ISIN: GB00B1VCP282

b)

Nature of the transaction

Ordinary Shares purchased

c)

Price(s) and volume(s)